Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN11682934
ISRCTN11682934
Completed
Not Applicable

Functional lung MRI for regional treatment monitoring of patients with cystic fibrosis: a case-control study

Hannover Medical School0 sites20 target enrollmentJune 19, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCystic fibrosisNutritional, Metabolic, Endocrine

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cystic fibrosis
Sponsor
Hannover Medical School
Enrollment
20
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients with cystic fibrosis
  • •2\. Aged between 12 and 24
  • •3\. Patients must be in a clinically stable condition with a confirmed diagnosis of cystic fibrosis
  • •4\. The forced expiratory volume in one second (FEV1\) must have a minimum volume of \>40 percent predicted for age and gender at the pre MRI lung function test

Exclusion Criteria

  • •1\. Pregnant or breastfeeding women
  • •2\. Cigarette smokers
  • •3\. Patients with hypertonic saline treatment (HST) within the last 7 days
  • •4\. Contraindications to MRI or contrast media (allergy to MRI or CT contrast media, GFR\< 30 mL/min/1\.73 m2\)
  • •5\. No (patient or parental) consent to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Functional magnetic resonance lung imaging using inhaled hyperpolarised 129XenoChronic obstructive pulmonary diseaseRespiratory
ISRCTN56900576niversity of Nottingham53
Active, not recruiting
Phase 1
Magnetic Resonance Imaging (MRI) in Bronchiectasis
EUCTR2019-003052-36-GBThe University of Nottingham40
Completed
Phase 1
Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis
NCT02478268Bastiaan Driehuys64
Recruiting
Not Applicable
Regional lung function measurement with electrical impedance tomograpy in non-invasive ventilated patient with acute exacerbation of bronchial asthma or COPDCOPDJ44J45Other chronic obstructive pulmonary diseaseAsthma
DRKS00010987Swisstom AG50
Active, not recruiting
Phase 1
Evaluation of the short-term effect of ORKAMBI on lung function in patients with cystic fibrosis who have two copies of the F508del mutation using functional respiratory imagingCystic Fibrosis Homozygous (homozygous for the F508del mutation)MedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2018-001573-24-BEAntwerp University Hospital20